China Pharmaceutical University, Center for Instrumental Analysis, Ministry of Education, Key Laboratory of Drug Quality Control & Pharmacovigilance, 210009 Nanjing, PR China.
Expert Opin Investig Drugs. 2009 Jul;18(7):875-85. doi: 10.1517/13543780903020308.
This perspective is part of an annual series of papers discussing drugs dropped from clinical development in the previous year. Specifically, this paper focuses on the 16 cardiovascular drugs discontinued in 2008. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase I-III clinical trials.
本观点是每年系列论文的一部分，讨论了上一年度从临床开发中淘汰的药物。具体而言，本文重点介绍了 2008 年被淘汰的 16 种心血管药物。本观点的信息来源于对 Pharmaprojects 数据库中在完成 I-III 期临床试验后被淘汰的药物进行搜索。
